| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/08/2004 | EP1453537A1 Composition for viral preservation |
| 09/08/2004 | EP1453536A1 Composition for the preservation of viruses |
| 09/08/2004 | EP1453535A2 Enveloped virus vaccine and method for production |
| 09/08/2004 | EP1453534A1 A process for the preparation of a non-toxic anthrax vaccine |
| 09/08/2004 | EP1453531A2 Use of hmgb proteins and nucleic acids that code therefor |
| 09/08/2004 | EP1453518A1 Pharmaceutical composition for the treatment of disorders of non-human mammals |
| 09/08/2004 | EP1453513A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer |
| 09/08/2004 | EP1453504A1 Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation |
| 09/08/2004 | EP1453471A2 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 09/08/2004 | EP1084261B1 Recombinant venezuelan equine encephalitis virus vaccine |
| 09/08/2004 | EP1053017B1 Vaccines comprising interleukin-12 and herpes simplex viral antigen |
| 09/08/2004 | EP0991426B1 Method for transferring nucleic acid into the striated muscle |
| 09/08/2004 | CN1527944A In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 09/08/2004 | CN1527883A Leporipox-based vector vaccines |
| 09/08/2004 | CN1527840A Use of CD 25 binding molecules in steroid-resistant patients |
| 09/08/2004 | CN1527724A Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 09/08/2004 | CN1527723A Methods for treating or preventing skin disorders using CD2-binding agents |
| 09/08/2004 | CN1527722A Smallpox vaccine |
| 09/08/2004 | CN1527699A Stable injecta composition and method |
| 09/08/2004 | CN1527697A Immune modulation device for use in animals |
| 09/08/2004 | CN1526735A Immune globulin and its prepn and application |
| 09/08/2004 | CN1526719A Deoxyoligonucleotide containing CpG single strand for strengthening immunological effect of Protein vaccine |
| 09/08/2004 | CN1526447A Human blood vessel IBP sample growth factor |
| 09/08/2004 | CN1526446A Recombinant phage vaccine of tumor proliferation related growth factor and its application |
| 09/08/2004 | CN1165764C Anti PSMA antibody or antigen binding part, and their use |
| 09/08/2004 | CN1165344C Compsns. and methods for catalyzing hydrolysis of HIV gp120 |
| 09/08/2004 | CN1165343C Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 09/08/2004 | CN1165342C Porcine reproductive and respiratory syndrome vaccine |
| 09/07/2004 | US6787643 Nucleic acid for use in kits for detection of preferential bacterial infection |
| 09/07/2004 | US6787637 Comprises administering agents that induce beneficial |
| 09/07/2004 | US6787634 Recognizes the extracellular domain of the human ifn-r and which has neutralizing capacity against the biological properties of human type i-ifn. |
| 09/07/2004 | US6787523 Alzheimer's disease, administering an a beta peptide and an adjuvant in a regime effective to induce an immune response comprising antibodies to the a beta peptide, the adjuvant enhancing the immune response to the a beta peptide, |
| 09/07/2004 | US6787517 Agent and methods for treating pain |
| 09/07/2004 | US6787354 Diagnosing and detecting cancer in mammals; obtain cells, isolate nucleotide sequences, detect hepsin nucleotide sequences, the presence of hepsin indicates hyperplasia |
| 09/07/2004 | US6787351 Composition for the prevention of preferential viral infections |
| 09/07/2004 | US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 09/07/2004 | US6787319 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease |
| 09/07/2004 | US6787303 Comprises polymerases, pol genes; for gene therapy |
| 09/07/2004 | US6787146 Vaccines against neosporosis useful in the prevention of clinical disease and abortion in mammals. |
| 09/07/2004 | US6787145 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 09/07/2004 | US6787144 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787143 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof |
| 09/07/2004 | US6787140 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787139 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787138 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787137 Campylobacter vaccine |
| 09/07/2004 | US6787133 Obtaining a preparation of mammalian telomerase enzyme purified from a crude cell extract; combining with a compound; determining telomerase activity of purified telomerase in presence of the compound; identifying telemerase activity |
| 09/02/2004 | WO2004074467A1 Inactivated nodavirus vaccine |
| 09/02/2004 | WO2004074454A2 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes |
| 09/02/2004 | WO2004074451A2 Loading of cells with antigens by electroporation |
| 09/02/2004 | WO2004074437A2 Compositions and methods for cancer immunotherapy |
| 09/02/2004 | WO2004074434A2 Methods and compositions for administering therapeutic and diagnostic agents |
| 09/02/2004 | WO2004074432A2 Antibody vaccine conjugates and uses therefor |
| 09/02/2004 | WO2004074323A1 Idiotypic vaccine |
| 09/02/2004 | WO2004074321A2 Therapeutic gpcr targets in cancer |
| 09/02/2004 | WO2004074320A2 Therapeutic targets in cancer |
| 09/02/2004 | WO2004074318A2 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof. |
| 09/02/2004 | WO2004074310A2 Mycobacterial diagnostics |
| 09/02/2004 | WO2004073738A2 Composition to be administered to a living being and method for marking agents |
| 09/02/2004 | WO2004073737A1 Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3 |
| 09/02/2004 | WO2004073736A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 09/02/2004 | WO2004073735A1 Improved anthrax vaccines and delivery methods |
| 09/02/2004 | WO2004073734A1 Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation |
| 09/02/2004 | WO2004073732A1 Modulators of notch signalling and of immune cell costimulatory activity for immunotherapy |
| 09/02/2004 | WO2004073728A2 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 09/02/2004 | WO2004073656A2 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/02/2004 | WO2004073653A2 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
| 09/02/2004 | WO2004073652A2 Powder formulations of recombinant staphylococcal enterotoxin b (rseb) made by atmospheric spray-freeze drying for improved vaccination |
| 09/02/2004 | WO2004073641A2 Induced activation in dendritic cells |
| 09/02/2004 | WO2004073624A2 Contraceptive methods and compositions related to proteasomal interference |
| 09/02/2004 | WO2004073604A2 Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity |
| 09/02/2004 | WO2004073603A2 Dna vaccine that expresses mutant adp-ribosyltransferase toxins which display reduced, or are devoid of, adp-ribosyltransferase activity |
| 09/02/2004 | WO2004073504A2 Methods for the treatment and prevention of diseases of biological conduits |
| 09/02/2004 | WO2004073499A2 Diagnosis of primary open angle glaucoma |
| 09/02/2004 | WO2004062559A3 Use of microcapsules comprising an antigen for the manufacture of an ex-vivo medicament to initiate an immune response |
| 09/02/2004 | WO2004062551A3 RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN |
| 09/02/2004 | WO2004059278A8 Methods of screening for anti-inflammatory drugs and use thereof |
| 09/02/2004 | WO2004034971A9 Methods for treating and preventing sepsis using modified c1 inhibitor or fragments thereof |
| 09/02/2004 | WO2004022657A3 Increasing of the resorption of substances via skin and mucous membranes |
| 09/02/2004 | WO2004018627A3 Methods for propagating adenovirus and virus produced thereby |
| 09/02/2004 | WO2004018000A3 Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | WO2004002421A3 Method for the treatment of multiple sclerosis |
| 09/02/2004 | WO2003101375A3 Immunostimulatory oligonucleotides and uses thereof |
| 09/02/2004 | WO2003080799A3 Polymorphic repetitive sequences in chlamydiae and uses thereof |
| 09/02/2004 | WO2003063910A3 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER |
| 09/02/2004 | WO2003048302A3 Identifying anti-tumor targets or agents by lipid raft immunization and proteomics |
| 09/02/2004 | WO2003015697A3 Interleukin-2 mutants with reduced toxicity |
| 09/02/2004 | WO2002072766A8 Induction of tumor immunity by variants of folate binding protein |
| 09/02/2004 | US20040172667 Administration of transposon-based vectors to reproductive organs |
| 09/02/2004 | US20040171821 Nucleotide sequences coding salivary polypeptide for use in development of vaccines for prevention and treatment of leishmanaisis; antiprotozoa agents; parsiticides |
| 09/02/2004 | US20040171816 Humanized antibodies that recognize beta amyloid peptide |
| 09/02/2004 | US20040171815 treatment of diseases associated with amyloid deposits in the brain (pre-clinical Alzheimer's disease or Down's syndrome); genetic engineering |
| 09/02/2004 | US20040171812 found in natural rubber that can induce an allergic reaction in persons who have been sensitised to it; for determining molecular weight, isoelectric point, amino acid sequence and allergenicity; for immunoassay/therapy |
| 09/02/2004 | US20040171807 involves engineering a recombinant shuttle vector comprising a nucleic acid cassette encoding prokaryotic green fluorescent protein (GFP) operably linked to regulatory sequences which permit its expression in a host cell |
| 09/02/2004 | US20040171806 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 09/02/2004 | US20040171805 including prevention and treatment of microbial diseases, diagnostic assays for detecting infection; for drug screening vaccines; genetic engineering |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171803 Artificial protein having potentiated immunogenicity of epitope |